| FSRPX | RYLSX | FSRPX / RYLSX | |
| Total Expense Ratio | 0.63 | 1.64 | 38% |
| Annual Report Gross Expense Ratio | 0.63 | 1.69 | 37% |
| Fund Existence | 41 years | 22 years | - |
| Gain YTD | 0.837 | -2.124 | -39% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | 500 | 1000 | 50% |
| Net Assets | 2.31B | 6.27M | 36,767% |
| Annual Yield % from dividends | 0.15 | 0.06 | 240% |
| Returns for 1 year | -8.40 | -2.83 | 297% |
| Returns for 3 years | -1.73 | 23.39 | -7% |
| Returns for 5 years | -26.74 | -2.49 | 1,072% |
| Returns for 10 years | 65.88 | 58.82 | 112% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IJPIX | 16.64 | 0.39 | +2.40% |
| VY® JPMorgan Emerging Markets Equity S | |||
| VSNGX | 69.90 | -0.18 | -0.26% |
| JPMorgan Mid Cap Equity I | |||
| JSIGX | 22.57 | -0.13 | -0.57% |
| Jacob Small Cap Growth Institutional | |||
| ETAHX | 53.90 | -0.88 | -1.61% |
| Eventide Healthcare & Life Sciences A | |||
| GLDIX | 41.59 | -1.24 | -2.90% |
| Gabelli Gold I | |||